Table V.
Treatment | Parameter | 95 Per cent lower bound | est. | 95 Per cent upper bound |
---|---|---|---|---|
1 | σ | 0.076 | 0.085 | 0.094 |
t50 | 64.027 | 100.835 | 137.642 | |
β | 0.996 | 1.485 | 1.975 | |
γ | −2.105 | −0.544 | 1.018 | |
η | 0.154 | 0.204 | 0.267 | |
σt50 | 48.090 | 69.649 | 100.872 | |
σβ | 0.606 | 0.911 | 1.368 | |
σγ | 1.432 | 2.412 | 4.062 | |
ση | 0.058 | 0.102 | 0.152 | |
cov(t50, β) | 0.407 | 0.751 | 0.909 | |
cov(t50, γ) | −0.642 | −0.146 | 0.435 | |
cov(t50, η) | 0.140 | 0.594 | 0.892 | |
cov(β, γ) | −0.688 | −0.268 | 0.287 | |
cov(β, η) | −0.091 | 0.521 | 0.912 | |
cov(γ, ρ) | −0.668 | −0.215 | 0.148 | |
2 | σ | 0.054 | 0.061 | 0.068 |
t50 | 199.452 | 244.443 | 289.44 | |
β | 2.033 | 2.497 | 2.961 | |
γ | −1.722 | 0.775 | 3.272 | |
η | 0.141 | 0.198 | 0.272 | |
σt50 | 35.519 | 60.099 | 101.690 | |
σβ | 0.322 | 0.585 | 1.062 | |
σγ | 1.836 | 3.269 | 5.823 | |
ση | 0.048 | 0.087 | 0.121 | |
cov(t50, β) | 0.012 | 0.687 | 0.932 | |
cov(t50, γ) | −0.014 | 0.643 | 0.912 | |
cov(t50, η) | −0.973 | −0.028 | 0.614 | |
cov(β, γ) | −0.221 | 0.569 | 0.908 | |
cov(β, η) | −0.064 | 0.596 | 0.942 | |
cov(γ, η) | −0.910 | 0.041 | 0.838 |
The estimates were obtained by EMMCEM using the 14 horses which received the test meal without atropine (treatment = 1) and seven horses which received the test meal along with atropine (treatment = 2).